Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 4.32965450 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32965450 |
3 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.31820838 |
4 | positive regulation of heat generation (GO:0031652) | 4.28396291 |
5 | L-phenylalanine metabolic process (GO:0006558) | 4.16427640 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.16427640 |
7 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.11420666 |
8 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.09342621 |
9 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.09342621 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 4.02233155 |
11 | axonemal dynein complex assembly (GO:0070286) | 3.85152036 |
12 | tryptophan catabolic process (GO:0006569) | 3.69670202 |
13 | indole-containing compound catabolic process (GO:0042436) | 3.69670202 |
14 | indolalkylamine catabolic process (GO:0046218) | 3.69670202 |
15 | killing of cells of other organism (GO:0031640) | 3.66630898 |
16 | disruption of cells of other organism (GO:0044364) | 3.66630898 |
17 | glyoxylate metabolic process (GO:0046487) | 3.64495607 |
18 | ribosomal small subunit assembly (GO:0000028) | 3.51111766 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.50681708 |
20 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49201322 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.48904543 |
22 | tryptophan metabolic process (GO:0006568) | 3.48466032 |
23 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.47429518 |
24 | epithelial cilium movement (GO:0003351) | 3.43472653 |
25 | regulation of fever generation (GO:0031620) | 3.40403466 |
26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31365243 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31365243 |
28 | kynurenine metabolic process (GO:0070189) | 3.29951258 |
29 | epoxygenase P450 pathway (GO:0019373) | 3.29108730 |
30 | regulation of heat generation (GO:0031650) | 3.28843628 |
31 | bile acid biosynthetic process (GO:0006699) | 3.28196328 |
32 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.26686219 |
33 | cysteine metabolic process (GO:0006534) | 3.24985708 |
34 | cilium movement (GO:0003341) | 3.23464918 |
35 | signal peptide processing (GO:0006465) | 3.23091425 |
36 | drug catabolic process (GO:0042737) | 3.21723145 |
37 | sulfur amino acid catabolic process (GO:0000098) | 3.18321366 |
38 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.17562195 |
39 | serine family amino acid biosynthetic process (GO:0009070) | 3.16184527 |
40 | regulation of cholesterol esterification (GO:0010872) | 3.13542483 |
41 | DNA deamination (GO:0045006) | 3.12742006 |
42 | plasma lipoprotein particle remodeling (GO:0034369) | 3.12473388 |
43 | protein-lipid complex remodeling (GO:0034368) | 3.12473388 |
44 | macromolecular complex remodeling (GO:0034367) | 3.12473388 |
45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12122878 |
46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.08759385 |
47 | motile cilium assembly (GO:0044458) | 3.08574597 |
48 | urea cycle (GO:0000050) | 3.07958303 |
49 | urea metabolic process (GO:0019627) | 3.07958303 |
50 | piRNA metabolic process (GO:0034587) | 3.02936588 |
51 | negative regulation of lipid storage (GO:0010888) | 3.02037147 |
52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01361591 |
53 | complement activation, alternative pathway (GO:0006957) | 3.01116073 |
54 | neutrophil mediated immunity (GO:0002446) | 3.00296634 |
55 | regulation of vitamin metabolic process (GO:0030656) | 3.00150317 |
56 | exogenous drug catabolic process (GO:0042738) | 2.99106431 |
57 | heme metabolic process (GO:0042168) | 2.95534542 |
58 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.94775050 |
59 | lysine catabolic process (GO:0006554) | 2.93707232 |
60 | lysine metabolic process (GO:0006553) | 2.93707232 |
61 | nitrogen cycle metabolic process (GO:0071941) | 2.93326494 |
62 | phospholipid efflux (GO:0033700) | 2.92769800 |
63 | cofactor catabolic process (GO:0051187) | 2.90159434 |
64 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.89761213 |
65 | regulation of triglyceride catabolic process (GO:0010896) | 2.89139961 |
66 | aromatic amino acid family metabolic process (GO:0009072) | 2.88776771 |
67 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.87774235 |
68 | ethanol oxidation (GO:0006069) | 2.86545788 |
69 | positive regulation of B cell differentiation (GO:0045579) | 2.86152659 |
70 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.84201279 |
71 | NAD biosynthetic process (GO:0009435) | 2.83514050 |
72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.83107959 |
73 | regulation of chronic inflammatory response (GO:0002676) | 2.82829327 |
74 | glutathione derivative biosynthetic process (GO:1901687) | 2.82028171 |
75 | glutathione derivative metabolic process (GO:1901685) | 2.82028171 |
76 | phenylpropanoid metabolic process (GO:0009698) | 2.81713072 |
77 | axoneme assembly (GO:0035082) | 2.81443603 |
78 | valine metabolic process (GO:0006573) | 2.81070835 |
79 | amyloid precursor protein catabolic process (GO:0042987) | 2.79534985 |
80 | regulation of protein activation cascade (GO:2000257) | 2.79265311 |
81 | L-serine metabolic process (GO:0006563) | 2.77974282 |
82 | regulation of fibrinolysis (GO:0051917) | 2.77780754 |
83 | positive regulation of acute inflammatory response (GO:0002675) | 2.77683218 |
84 | glycine metabolic process (GO:0006544) | 2.77266812 |
85 | reactive oxygen species biosynthetic process (GO:1903409) | 2.76802490 |
86 | heme biosynthetic process (GO:0006783) | 2.76544815 |
87 | aldehyde catabolic process (GO:0046185) | 2.76497935 |
88 | primary alcohol catabolic process (GO:0034310) | 2.73677530 |
89 | omega-hydroxylase P450 pathway (GO:0097267) | 2.72125142 |
90 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.71274739 |
91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.71274739 |
92 | positive regulation of prostaglandin secretion (GO:0032308) | 2.70773582 |
93 | serine family amino acid metabolic process (GO:0009069) | 2.70549181 |
94 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.70364114 |
95 | imidazole-containing compound metabolic process (GO:0052803) | 2.70186177 |
96 | amino-acid betaine metabolic process (GO:0006577) | 2.69693976 |
97 | respiratory burst (GO:0045730) | 2.69104285 |
98 | drug metabolic process (GO:0017144) | 2.68046809 |
99 | benzene-containing compound metabolic process (GO:0042537) | 2.67658964 |
100 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.67480080 |
101 | negative regulation of fibrinolysis (GO:0051918) | 2.65431848 |
102 | neutrophil activation involved in immune response (GO:0002283) | 2.65153648 |
103 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.65027409 |
104 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.65027409 |
105 | regulation of growth of symbiont in host (GO:0044126) | 2.65027409 |
106 | negative regulation of growth of symbiont in host (GO:0044130) | 2.65027409 |
107 | bile acid metabolic process (GO:0008206) | 2.64887126 |
108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.64838367 |
109 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.64838367 |
110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64449151 |
111 | regulation of complement activation (GO:0030449) | 2.63307997 |
112 | cellular biogenic amine catabolic process (GO:0042402) | 2.63115690 |
113 | amine catabolic process (GO:0009310) | 2.63115690 |
114 | alkaloid metabolic process (GO:0009820) | 2.62252023 |
115 | negative regulation of sterol transport (GO:0032372) | 2.62033244 |
116 | negative regulation of cholesterol transport (GO:0032375) | 2.62033244 |
117 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.60684831 |
118 | defense response to fungus (GO:0050832) | 2.59897525 |
119 | response to nitrosative stress (GO:0051409) | 2.58894189 |
120 | cholesterol efflux (GO:0033344) | 2.58866716 |
121 | reverse cholesterol transport (GO:0043691) | 2.58757091 |
122 | plasma lipoprotein particle assembly (GO:0034377) | 2.58695228 |
123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.58240651 |
124 | response to peptidoglycan (GO:0032494) | 2.58191613 |
125 | T-helper 1 type immune response (GO:0042088) | 2.57731999 |
126 | regulation of chemokine biosynthetic process (GO:0045073) | 2.57555325 |
127 | cobalamin metabolic process (GO:0009235) | 2.56835284 |
128 | alpha-amino acid catabolic process (GO:1901606) | 2.56310202 |
129 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56307642 |
130 | plasma lipoprotein particle organization (GO:0071827) | 2.56174765 |
131 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.55829253 |
132 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55478039 |
133 | fibrinolysis (GO:0042730) | 2.54675737 |
134 | protein carboxylation (GO:0018214) | 2.54474345 |
135 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54474345 |
136 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.52313876 |
137 | pyrimidine nucleoside salvage (GO:0043097) | 2.51548360 |
138 | pyrimidine-containing compound salvage (GO:0008655) | 2.51548360 |
139 | indolalkylamine metabolic process (GO:0006586) | 2.50490417 |
140 | coenzyme catabolic process (GO:0009109) | 2.50478377 |
141 | nucleoside salvage (GO:0043174) | 2.50202361 |
142 | xenobiotic catabolic process (GO:0042178) | 2.49896754 |
143 | acute-phase response (GO:0006953) | 2.49788945 |
144 | complement activation, classical pathway (GO:0006958) | 2.49473803 |
145 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49449137 |
146 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.49103797 |
147 | tyrosine metabolic process (GO:0006570) | 2.48851481 |
148 | cellular response to ethanol (GO:0071361) | 2.48139785 |
149 | opsonization (GO:0008228) | 2.46889875 |
150 | regulation of immunoglobulin secretion (GO:0051023) | 2.44730015 |
151 | peroxisome fission (GO:0016559) | 2.42005828 |
152 | positive regulation of icosanoid secretion (GO:0032305) | 2.41882131 |
153 | positive regulation of fatty acid transport (GO:2000193) | 2.41587432 |
154 | cellular ketone body metabolic process (GO:0046950) | 2.37937912 |
155 | detection of light stimulus involved in visual perception (GO:0050908) | 2.36403034 |
156 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.36403034 |
157 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.35854683 |
158 | negative regulation of interleukin-1 production (GO:0032692) | 2.35611647 |
159 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.35593279 |
160 | oligosaccharide catabolic process (GO:0009313) | 2.33921754 |
161 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.33744587 |
162 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.30434359 |
163 | phospholipid homeostasis (GO:0055091) | 2.29531652 |
164 | regulation of acute inflammatory response (GO:0002673) | 2.27971090 |
165 | bile acid and bile salt transport (GO:0015721) | 2.26844935 |
166 | negative regulation of lipid catabolic process (GO:0050995) | 2.25700146 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.97615660 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.78195528 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27099195 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.20126986 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19484899 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07111856 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.98900873 |
8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95903614 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72493047 |
10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56377543 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.49617248 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.36396044 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30954324 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.29586321 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28185954 |
16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.26707832 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.17257838 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14323183 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11954391 |
20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08444811 |
21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.04103658 |
22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.98329690 |
23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97702162 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96517780 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95586912 |
26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93937508 |
27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90205564 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83641489 |
29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.83020420 |
30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.81366708 |
31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76381257 |
32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76032014 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75385593 |
34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74230571 |
35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.74145833 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72290459 |
37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70969008 |
38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69918252 |
39 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.67213938 |
40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67062936 |
41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64246352 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63874952 |
43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.62238001 |
44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59437759 |
45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58869689 |
46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56919285 |
47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56771973 |
48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56545750 |
49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56484165 |
50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56255696 |
51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56128113 |
52 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55605822 |
53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.55302418 |
54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53702792 |
55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51869834 |
56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51682806 |
57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51534786 |
58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.49100536 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47243064 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44320522 |
61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43975486 |
62 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38195832 |
63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38195832 |
64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37971514 |
65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37857486 |
66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36631497 |
67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35369843 |
68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35231507 |
69 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.34749577 |
70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33858011 |
71 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32535956 |
72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32535956 |
73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32324430 |
74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32314136 |
75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31186005 |
76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30550001 |
77 | MYB_26560356_Chip-Seq_TH2_Human | 1.30264796 |
78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28204424 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28115170 |
80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27947134 |
81 | MYC_22102868_ChIP-Seq_BL_Human | 1.27804399 |
82 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27562474 |
83 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.27479593 |
84 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27223156 |
85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26880371 |
86 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25698506 |
87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24489925 |
88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24293785 |
89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24028919 |
90 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23371152 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22420958 |
92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22136073 |
93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22037766 |
94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21842643 |
95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.21040853 |
96 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20998398 |
97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19361694 |
98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17972203 |
99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17173304 |
100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15657639 |
101 | MAF_26560356_Chip-Seq_TH1_Human | 1.14934783 |
102 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14555208 |
103 | MYB_26560356_Chip-Seq_TH1_Human | 1.13895927 |
104 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13234215 |
105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12864902 |
106 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12776045 |
107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12412932 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10691704 |
109 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10521537 |
110 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08526543 |
111 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08322665 |
112 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06875956 |
113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06173164 |
114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05165897 |
115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04989691 |
116 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04986700 |
117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04986700 |
118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04628997 |
119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04524506 |
120 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03793319 |
121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03518801 |
122 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03246538 |
123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03007994 |
124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01358720 |
125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01140517 |
126 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00929784 |
127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00407113 |
128 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99982938 |
129 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99305646 |
130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99248421 |
131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99163098 |
132 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99027670 |
133 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98398310 |
134 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97862101 |
135 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97740976 |
136 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97391433 |
137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97292844 |
138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97069592 |
139 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96867813 |
140 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96036968 |
141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95460991 |
142 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95381819 |
143 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95235590 |
144 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95050527 |
145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94865989 |
146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94671462 |
147 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94481983 |
148 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94476528 |
149 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93721041 |
150 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93578367 |
151 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93407069 |
152 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92246309 |
153 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91534915 |
154 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91456554 |
155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90991573 |
156 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90411382 |
157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90132600 |
158 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90047240 |
159 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89719169 |
160 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89634188 |
161 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88407081 |
162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88373505 |
163 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87558798 |
164 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87507443 |
165 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86927843 |
166 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.86776217 |
167 | CBP_21632823_ChIP-Seq_H3396_Human | 0.86629074 |
168 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86176260 |
169 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86105166 |
170 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85938579 |
171 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85675456 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.56077836 |
2 | MP0005360_urolithiasis | 4.13375132 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.93130597 |
4 | MP0005365_abnormal_bile_salt | 3.65812902 |
5 | MP0008004_abnormal_stomach_pH | 3.45161471 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.39328943 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.24727320 |
8 | MP0001835_abnormal_antigen_presentation | 2.61286592 |
9 | MP0009840_abnormal_foam_cell | 2.44772339 |
10 | MP0003656_abnormal_erythrocyte_physiolo | 2.42074463 |
11 | MP0003186_abnormal_redox_activity | 2.29270064 |
12 | MP0009785_altered_susceptibility_to | 2.16817976 |
13 | MP0003436_decreased_susceptibility_to | 2.16763870 |
14 | MP0001666_abnormal_nutrient_absorption | 2.05390963 |
15 | MP0010329_abnormal_lipoprotein_level | 1.96366242 |
16 | MP0000685_abnormal_immune_system | 1.94979339 |
17 | MP0003724_increased_susceptibility_to | 1.88535614 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.87745352 |
19 | MP0002396_abnormal_hematopoietic_system | 1.86304833 |
20 | MP0005025_abnormal_response_to | 1.85810079 |
21 | MP0001764_abnormal_homeostasis | 1.85660565 |
22 | MP0002419_abnormal_innate_immunity | 1.80519200 |
23 | MP0002148_abnormal_hypersensitivity_rea | 1.80061136 |
24 | MP0002332_abnormal_exercise_endurance | 1.76908023 |
25 | MP0005083_abnormal_biliary_tract | 1.76126132 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.74648134 |
27 | MP0005332_abnormal_amino_acid | 1.74252451 |
28 | MP0001800_abnormal_humoral_immune | 1.72118165 |
29 | MP0003252_abnormal_bile_duct | 1.69354367 |
30 | MP0005671_abnormal_response_to | 1.68913460 |
31 | MP0005464_abnormal_platelet_physiology | 1.67145904 |
32 | MP0000609_abnormal_liver_physiology | 1.64638183 |
33 | MP0005075_abnormal_melanosome_morpholog | 1.64528738 |
34 | MP0003195_calcinosis | 1.63749782 |
35 | MP0005410_abnormal_fertilization | 1.63510386 |
36 | MP0002166_altered_tumor_susceptibility | 1.61116339 |
37 | MP0005000_abnormal_immune_tolerance | 1.60715268 |
38 | MP0005387_immune_system_phenotype | 1.57395543 |
39 | MP0001790_abnormal_immune_system | 1.57395543 |
40 | MP0002132_abnormal_respiratory_system | 1.53732345 |
41 | MP0008469_abnormal_protein_level | 1.52001469 |
42 | MP0002723_abnormal_immune_serum | 1.51852258 |
43 | MP0003763_abnormal_thymus_physiology | 1.51801424 |
44 | MP0003646_muscle_fatigue | 1.51339932 |
45 | MP0003075_altered_response_to | 1.51123342 |
46 | MP0001501_abnormal_sleep_pattern | 1.50880635 |
47 | MP0005319_abnormal_enzyme/_coenzyme | 1.50532750 |
48 | MP0001545_abnormal_hematopoietic_system | 1.47032634 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.47032634 |
50 | MP0002452_abnormal_antigen_presenting | 1.46747525 |
51 | MP0005058_abnormal_lysosome_morphology | 1.45703985 |
52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44952044 |
53 | MP0002420_abnormal_adaptive_immunity | 1.43071753 |
54 | MP0006036_abnormal_mitochondrial_physio | 1.42332718 |
55 | MP0004147_increased_porphyrin_level | 1.41222792 |
56 | MP0009278_abnormal_bone_marrow | 1.40796748 |
57 | MP0001819_abnormal_immune_cell | 1.40662639 |
58 | MP0009643_abnormal_urine_homeostasis | 1.38501319 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.38222742 |
60 | MP0000490_abnormal_crypts_of | 1.37532057 |
61 | MP0001845_abnormal_inflammatory_respons | 1.36732141 |
62 | MP0003011_delayed_dark_adaptation | 1.36488251 |
63 | MP0005408_hypopigmentation | 1.35926382 |
64 | MP0004019_abnormal_vitamin_homeostasis | 1.33764418 |
65 | MP0005167_abnormal_blood-brain_barrier | 1.33743132 |
66 | MP0010155_abnormal_intestine_physiology | 1.32885752 |
67 | MP0004043_abnormal_pH_regulation | 1.31232486 |
68 | MP0002398_abnormal_bone_marrow | 1.31097622 |
69 | MP0000716_abnormal_immune_system | 1.27798664 |
70 | MP0002405_respiratory_system_inflammati | 1.27701816 |
71 | MP0002118_abnormal_lipid_homeostasis | 1.26501307 |
72 | MP0003172_abnormal_lysosome_physiology | 1.26487603 |
73 | MP0001853_heart_inflammation | 1.25328942 |
74 | MP0000689_abnormal_spleen_morphology | 1.25214811 |
75 | MP0003693_abnormal_embryo_hatching | 1.21776371 |
76 | MP0009763_increased_sensitivity_to | 1.19972354 |
77 | MP0009764_decreased_sensitivity_to | 1.17995008 |
78 | MP0002429_abnormal_blood_cell | 1.16975399 |
79 | MP0005670_abnormal_white_adipose | 1.16710265 |
80 | MP0002722_abnormal_immune_system | 1.15477156 |
81 | MP0004510_myositis | 1.14912998 |
82 | MP0006082_CNS_inflammation | 1.13376907 |
83 | MP0005636_abnormal_mineral_homeostasis | 1.13176867 |
84 | MP0003183_abnormal_peptide_metabolism | 1.10928367 |
85 | MP0005166_decreased_susceptibility_to | 1.10603332 |
86 | MP0002736_abnormal_nociception_after | 1.10327749 |
87 | MP0000598_abnormal_liver_morphology | 1.06291361 |
88 | MP0005535_abnormal_body_temperature | 1.06058223 |
89 | MP0002006_tumorigenesis | 1.04053101 |
90 | MP0003868_abnormal_feces_composition | 1.03713429 |
91 | MP0003718_maternal_effect | 1.02936155 |
92 | MP0000569_abnormal_digit_pigmentation | 1.02194732 |
93 | MP0005451_abnormal_body_composition | 1.01479537 |
94 | MP0008877_abnormal_DNA_methylation | 0.98296231 |
95 | MP0005164_abnormal_response_to | 0.93917326 |
96 | MP0002876_abnormal_thyroid_physiology | 0.93915706 |
97 | MP0003303_peritoneal_inflammation | 0.93600017 |
98 | MP0004947_skin_inflammation | 0.92892358 |
99 | MP0008057_abnormal_DNA_replication | 0.92500058 |
100 | MP0000604_amyloidosis | 0.92266360 |
101 | MP0002277_abnormal_respiratory_mucosa | 0.91915723 |
102 | MP0001873_stomach_inflammation | 0.91367705 |
103 | MP0005377_hearing/vestibular/ear_phenot | 0.91243896 |
104 | MP0003878_abnormal_ear_physiology | 0.91243896 |
105 | MP0003866_abnormal_defecation | 0.88594810 |
106 | MP0005551_abnormal_eye_electrophysiolog | 0.87789508 |
107 | MP0000465_gastrointestinal_hemorrhage | 0.86718655 |
108 | MP0005376_homeostasis/metabolism_phenot | 0.85414334 |
109 | MP0006054_spinal_hemorrhage | 0.84537420 |
110 | MP0009697_abnormal_copulation | 0.84019807 |
111 | MP0000343_altered_response_to | 0.84017980 |
112 | MP0002653_abnormal_ependyma_morphology | 0.82926479 |
113 | MP0006035_abnormal_mitochondrial_morpho | 0.82239763 |
114 | MP0005174_abnormal_tail_pigmentation | 0.81997842 |
115 | MP0004264_abnormal_extraembryonic_tissu | 0.81863873 |
116 | MP0010094_abnormal_chromosome_stability | 0.81397770 |
117 | MP0001533_abnormal_skeleton_physiology | 0.81276730 |
118 | MP0002019_abnormal_tumor_incidence | 0.80132677 |
119 | MP0005310_abnormal_salivary_gland | 0.79988866 |
120 | MP0009642_abnormal_blood_homeostasis | 0.79707608 |
121 | MP0000858_altered_metastatic_potential | 0.79458821 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.78271499 |
123 | MP0002254_reproductive_system_inflammat | 0.78207241 |
124 | MP0005220_abnormal_exocrine_pancreas | 0.75388785 |
125 | MP0005647_abnormal_sex_gland | 0.75270913 |
126 | MP0004381_abnormal_hair_follicle | 0.73621466 |
127 | MP0005266_abnormal_metabolism | 0.73440881 |
128 | MP0001663_abnormal_digestive_system | 0.73370385 |
129 | MP0008873_increased_physiological_sensi | 0.73367385 |
130 | MP0005395_other_phenotype | 0.72961224 |
131 | MP0003879_abnormal_hair_cell | 0.67806570 |
132 | MP0000230_abnormal_systemic_arterial | 0.67304567 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.41980855 |
2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.26891179 |
3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.97980197 |
4 | Abnormal ciliary motility (HP:0012262) | 3.95044276 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.91405997 |
6 | Absent/shortened dynein arms (HP:0200106) | 3.88958473 |
7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.88958473 |
8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.84038623 |
9 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.84038623 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 3.63529183 |
11 | Intrahepatic cholestasis (HP:0001406) | 3.60370619 |
12 | Hypobetalipoproteinemia (HP:0003563) | 3.49270303 |
13 | Rhinitis (HP:0012384) | 3.38493937 |
14 | Deep venous thrombosis (HP:0002625) | 3.18834346 |
15 | Joint hemorrhage (HP:0005261) | 3.18417333 |
16 | Recurrent bacterial skin infections (HP:0005406) | 3.16736756 |
17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14464755 |
18 | Xanthomatosis (HP:0000991) | 3.09428493 |
19 | Stomatitis (HP:0010280) | 3.08772211 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06768060 |
21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.00412944 |
22 | Retrobulbar optic neuritis (HP:0100654) | 3.00005051 |
23 | Optic neuritis (HP:0100653) | 3.00005051 |
24 | IgM deficiency (HP:0002850) | 2.99894227 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99211704 |
26 | Generalized aminoaciduria (HP:0002909) | 2.98485397 |
27 | Thrombocytosis (HP:0001894) | 2.97258809 |
28 | Recurrent abscess formation (HP:0002722) | 2.95805818 |
29 | Hyperammonemia (HP:0001987) | 2.94991014 |
30 | Hypoglycemic coma (HP:0001325) | 2.93350059 |
31 | Hyperbilirubinemia (HP:0002904) | 2.93147572 |
32 | Hyperlipoproteinemia (HP:0010980) | 2.92237012 |
33 | Complement deficiency (HP:0004431) | 2.92173166 |
34 | Orchitis (HP:0100796) | 2.86730547 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82109372 |
36 | Dicarboxylic aciduria (HP:0003215) | 2.82109372 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77025614 |
38 | Abnormal number of erythroid precursors (HP:0012131) | 2.75563449 |
39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.75524780 |
40 | Systemic lupus erythematosus (HP:0002725) | 2.75466777 |
41 | Amyloidosis (HP:0011034) | 2.73836429 |
42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66014714 |
43 | Pancreatic cysts (HP:0001737) | 2.63554747 |
44 | Ketosis (HP:0001946) | 2.61211589 |
45 | Vacuolated lymphocytes (HP:0001922) | 2.58542965 |
46 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.57570485 |
47 | Reduced antithrombin III activity (HP:0001976) | 2.57212446 |
48 | Chronic otitis media (HP:0000389) | 2.54630363 |
49 | Fat malabsorption (HP:0002630) | 2.54439179 |
50 | Hepatic necrosis (HP:0002605) | 2.54437955 |
51 | Eczematoid dermatitis (HP:0000976) | 2.52985919 |
52 | Bronchiectasis (HP:0002110) | 2.49671923 |
53 | Abnormality of methionine metabolism (HP:0010901) | 2.49580027 |
54 | Petechiae (HP:0000967) | 2.45107709 |
55 | Abnormality of complement system (HP:0005339) | 2.45044085 |
56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.42635645 |
57 | True hermaphroditism (HP:0010459) | 2.41973582 |
58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.41053213 |
59 | Severe visual impairment (HP:0001141) | 2.40664677 |
60 | Hypoplasia of the thymus (HP:0000778) | 2.37469763 |
61 | Pancreatic fibrosis (HP:0100732) | 2.37326231 |
62 | Aplastic anemia (HP:0001915) | 2.35418831 |
63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32215019 |
64 | Abnormality of glycine metabolism (HP:0010895) | 2.32215019 |
65 | Reticulocytopenia (HP:0001896) | 2.32183528 |
66 | Hyperglycinuria (HP:0003108) | 2.31315277 |
67 | Hyperglycinemia (HP:0002154) | 2.28998558 |
68 | Molar tooth sign on MRI (HP:0002419) | 2.27104764 |
69 | Abnormality of midbrain morphology (HP:0002418) | 2.27104764 |
70 | Steatorrhea (HP:0002570) | 2.25177476 |
71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.24736601 |
72 | Recurrent skin infections (HP:0001581) | 2.24309260 |
73 | Methylmalonic aciduria (HP:0012120) | 2.22732539 |
74 | Hypolipoproteinemia (HP:0010981) | 2.22671815 |
75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.21877097 |
76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20154109 |
77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20154109 |
78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20154109 |
79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.19046633 |
80 | Chronic hepatic failure (HP:0100626) | 2.18916631 |
81 | Neutropenia (HP:0001875) | 2.18017332 |
82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.17998772 |
83 | Tubulointerstitial nephritis (HP:0001970) | 2.17986495 |
84 | Gangrene (HP:0100758) | 2.16146149 |
85 | Abnormality of the renal cortex (HP:0011035) | 2.15961508 |
86 | Abnormality of T cell physiology (HP:0011840) | 2.15934041 |
87 | Abnormality of iron homeostasis (HP:0011031) | 2.15642172 |
88 | Medial flaring of the eyebrow (HP:0010747) | 2.15285256 |
89 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14178243 |
90 | Cerebral edema (HP:0002181) | 2.13699687 |
91 | Hepatocellular necrosis (HP:0001404) | 2.12822733 |
92 | Lethargy (HP:0001254) | 2.12296569 |
93 | Autoimmune thrombocytopenia (HP:0001973) | 2.12277117 |
94 | Nausea (HP:0002018) | 2.10446340 |
95 | Nasal polyposis (HP:0100582) | 2.09537107 |
96 | Epistaxis (HP:0000421) | 2.09051885 |
97 | Glycosuria (HP:0003076) | 2.08124285 |
98 | Abnormality of urine glucose concentration (HP:0011016) | 2.08124285 |
99 | Recurrent viral infections (HP:0004429) | 2.07183066 |
100 | Gingival bleeding (HP:0000225) | 2.06343289 |
101 | Nephronophthisis (HP:0000090) | 2.06005026 |
102 | Abnormality of macrophages (HP:0004311) | 2.05894995 |
103 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05826568 |
104 | Increased serum ferritin (HP:0003281) | 2.05606992 |
105 | Chronic bronchitis (HP:0004469) | 2.04451910 |
106 | Metabolic acidosis (HP:0001942) | 2.02913446 |
107 | Myositis (HP:0100614) | 2.02622320 |
108 | Encephalitis (HP:0002383) | 2.02612395 |
109 | Renal cortical cysts (HP:0000803) | 2.02574429 |
110 | Acute encephalopathy (HP:0006846) | 2.01725302 |
111 | Recurrent bronchitis (HP:0002837) | 2.00939627 |
112 | Abnormality of the prostate (HP:0008775) | 2.00193456 |
113 | Glomerulonephritis (HP:0000099) | 1.99410378 |
114 | Acanthocytosis (HP:0001927) | 1.98783795 |
115 | Panhypogammaglobulinemia (HP:0003139) | 1.97993140 |
116 | Ketoacidosis (HP:0001993) | 1.97816034 |
117 | Spontaneous hematomas (HP:0007420) | 1.97539476 |
118 | Pustule (HP:0200039) | 1.97475210 |
119 | Increased cerebral lipofuscin (HP:0011813) | 1.96799656 |
120 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96699855 |
121 | Poikilocytosis (HP:0004447) | 1.96181043 |
122 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95336038 |
123 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94911240 |
124 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94911240 |
125 | Congenital stationary night blindness (HP:0007642) | 1.94548979 |
126 | Joint swelling (HP:0001386) | 1.93425949 |
127 | Granulocytopenia (HP:0001913) | 1.93307512 |
128 | Meningitis (HP:0001287) | 1.93138164 |
129 | Vomiting (HP:0002013) | 1.92873542 |
130 | Azoospermia (HP:0000027) | 1.92834792 |
131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92560700 |
132 | Recurrent sinusitis (HP:0011108) | 1.92228187 |
133 | Pancreatitis (HP:0001733) | 1.92060603 |
134 | Abnormality of serum amino acid levels (HP:0003112) | 1.91737715 |
135 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91189593 |
136 | Delayed CNS myelination (HP:0002188) | 1.90997614 |
137 | Pancytopenia (HP:0001876) | 1.90389368 |
138 | Periodontitis (HP:0000704) | 1.90178784 |
139 | Abnormality of the renal medulla (HP:0100957) | 1.89289540 |
140 | Type I transferrin isoform profile (HP:0003642) | 1.88958815 |
141 | Parakeratosis (HP:0001036) | 1.88246753 |
142 | Keratoconjunctivitis sicca (HP:0001097) | 1.88164648 |
143 | Eosinophilia (HP:0001880) | 1.88025954 |
144 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87025570 |
145 | Increased CSF lactate (HP:0002490) | 1.85151628 |
146 | Mitochondrial inheritance (HP:0001427) | 1.84820431 |
147 | Autoimmune hemolytic anemia (HP:0001890) | 1.84542877 |
148 | Spontaneous abortion (HP:0005268) | 1.82891748 |
149 | Acute necrotizing encephalopathy (HP:0006965) | 1.80401422 |
150 | Pigmentary retinal degeneration (HP:0001146) | 1.78708456 |
151 | Decreased central vision (HP:0007663) | 1.78455196 |
152 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.76958877 |
153 | Episodic fever (HP:0001954) | 1.75930825 |
154 | Anorexia (HP:0002039) | 1.75635109 |
155 | Keratoconjunctivitis (HP:0001096) | 1.74382083 |
156 | Congenital hepatic fibrosis (HP:0002612) | 1.74350906 |
157 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73436991 |
158 | Stomach cancer (HP:0012126) | 1.71679006 |
159 | Methylmalonic acidemia (HP:0002912) | 1.70246632 |
160 | Hypoalphalipoproteinemia (HP:0003233) | 1.70104459 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 4.43682643 |
2 | MAP4K1 | 3.01845501 |
3 | PDK2 | 2.88843830 |
4 | TAOK3 | 2.81354990 |
5 | STK16 | 2.79088942 |
6 | PIM2 | 2.73023041 |
7 | BCKDK | 2.71120168 |
8 | BLK | 2.70953340 |
9 | KIT | 2.56803190 |
10 | TEC | 2.55917738 |
11 | NME2 | 2.54896999 |
12 | IRAK4 | 2.52442941 |
13 | ERN1 | 2.41267914 |
14 | BTK | 2.34309675 |
15 | TBK1 | 2.19473807 |
16 | FLT3 | 2.12320137 |
17 | GRK7 | 2.10939397 |
18 | TYK2 | 2.10357702 |
19 | PINK1 | 2.04605122 |
20 | MAP4K2 | 1.98359783 |
21 | IRAK3 | 1.88604534 |
22 | ZAP70 | 1.87680088 |
23 | IRAK2 | 1.84676765 |
24 | MAP3K14 | 1.72284721 |
25 | ADRBK2 | 1.68285233 |
26 | IKBKE | 1.66052919 |
27 | TNK2 | 1.61532952 |
28 | EPHB1 | 1.54485002 |
29 | MAP3K3 | 1.53382946 |
30 | BMPR2 | 1.49200387 |
31 | CSF1R | 1.48770671 |
32 | JAK3 | 1.45084428 |
33 | MAP3K6 | 1.43983170 |
34 | EIF2AK1 | 1.43832182 |
35 | SYK | 1.42651716 |
36 | FGFR4 | 1.39094316 |
37 | STK38L | 1.38591515 |
38 | MAP2K3 | 1.37582675 |
39 | CLK1 | 1.37031671 |
40 | EIF2AK3 | 1.33617526 |
41 | VRK1 | 1.33313479 |
42 | GRK1 | 1.33200324 |
43 | TXK | 1.31067220 |
44 | ARAF | 1.30262590 |
45 | BUB1 | 1.24586480 |
46 | ITK | 1.23531008 |
47 | WNK3 | 1.23199010 |
48 | STK10 | 1.21635406 |
49 | IKBKB | 1.19496955 |
50 | KDR | 1.19087770 |
51 | TNIK | 1.17185940 |
52 | MUSK | 1.16991708 |
53 | OXSR1 | 1.16393190 |
54 | ABL2 | 1.14699940 |
55 | BMPR1B | 1.14352721 |
56 | PTK2B | 1.13418499 |
57 | PASK | 1.08447863 |
58 | ACVR1B | 1.08017234 |
59 | MAP3K11 | 1.07947695 |
60 | LYN | 1.05834205 |
61 | NLK | 0.99174015 |
62 | PIM1 | 0.98090337 |
63 | GRK6 | 0.96645189 |
64 | LRRK2 | 0.95657967 |
65 | NME1 | 0.94693598 |
66 | INSRR | 0.92056320 |
67 | TESK2 | 0.91290088 |
68 | TAOK2 | 0.90655481 |
69 | JAK1 | 0.90500988 |
70 | BRAF | 0.88510771 |
71 | OBSCN | 0.88354121 |
72 | MAPK15 | 0.84845987 |
73 | MAP3K12 | 0.84298286 |
74 | ZAK | 0.83670394 |
75 | LCK | 0.82319144 |
76 | FES | 0.81549380 |
77 | STK4 | 0.81332744 |
78 | MAPK4 | 0.80772799 |
79 | AKT3 | 0.80065643 |
80 | JAK2 | 0.80030722 |
81 | MAP3K4 | 0.79569197 |
82 | SIK1 | 0.79134099 |
83 | EPHA3 | 0.78819251 |
84 | PBK | 0.78778844 |
85 | CDK4 | 0.78202060 |
86 | MST4 | 0.75685227 |
87 | MAPK13 | 0.75191436 |
88 | NTRK3 | 0.75149945 |
89 | MAPK11 | 0.74224782 |
90 | WEE1 | 0.72840822 |
91 | RIPK4 | 0.72775042 |
92 | PRKAA2 | 0.71644833 |
93 | TLK1 | 0.70364698 |
94 | MAP3K13 | 0.69403466 |
95 | DYRK3 | 0.63866124 |
96 | PIK3CG | 0.63808946 |
97 | MAP3K5 | 0.63604514 |
98 | MAP3K8 | 0.61559043 |
99 | STK38 | 0.60652416 |
100 | CSK | 0.59468126 |
101 | TESK1 | 0.57772010 |
102 | CAMKK2 | 0.57337860 |
103 | STK24 | 0.56489613 |
104 | CDK7 | 0.56336717 |
105 | RPS6KA6 | 0.55991743 |
106 | IRAK1 | 0.55963491 |
107 | TGFBR1 | 0.55595893 |
108 | CCNB1 | 0.55155635 |
109 | ATR | 0.54207843 |
110 | NUAK1 | 0.53952789 |
111 | HCK | 0.52297974 |
112 | FER | 0.52117272 |
113 | MAP2K7 | 0.51486244 |
114 | PRKCD | 0.51465699 |
115 | MAPKAPK3 | 0.50415991 |
116 | MAP2K6 | 0.50394350 |
117 | EPHA2 | 0.49278307 |
118 | RAF1 | 0.48895498 |
119 | DAPK2 | 0.48738130 |
120 | RPS6KL1 | 0.48015272 |
121 | RPS6KC1 | 0.48015272 |
122 | PRKCQ | 0.46326583 |
123 | TRIM28 | 0.46276865 |
124 | SCYL2 | 0.44966758 |
125 | MATK | 0.44787654 |
126 | RPS6KA4 | 0.44680832 |
127 | PDK1 | 0.44115471 |
128 | CHUK | 0.43073385 |
129 | HIPK2 | 0.43014800 |
130 | MAP3K1 | 0.41972323 |
131 | CASK | 0.41229468 |
132 | IGF1R | 0.39876338 |
133 | MOS | 0.39690057 |
134 | TGFBR2 | 0.39426837 |
135 | PRKACG | 0.38873474 |
136 | LMTK2 | 0.38871033 |
137 | CDK6 | 0.38416072 |
138 | CDK19 | 0.38410085 |
139 | BRSK2 | 0.38266935 |
140 | MAPK7 | 0.37670524 |
141 | CDC7 | 0.37384317 |
142 | MST1R | 0.36495634 |
143 | CSNK2A1 | 0.35609098 |
144 | MARK3 | 0.35517631 |
145 | PRKG2 | 0.35506454 |
146 | ADRBK1 | 0.34537991 |
147 | AURKB | 0.33875896 |
148 | PKN1 | 0.33835898 |
149 | TTK | 0.32839841 |
150 | CSNK1A1L | 0.32732119 |
151 | EIF2AK2 | 0.31801477 |
152 | BCR | 0.31682341 |
153 | SGK3 | 0.30776025 |
154 | MAPKAPK2 | 0.30622392 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11697188 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41149748 |
3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16984076 |
4 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.07898082 |
5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02581394 |
6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02367663 |
7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.98234408 |
8 | Peroxisome_Homo sapiens_hsa04146 | 1.92214663 |
9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88506217 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87131141 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84239344 |
12 | Protein export_Homo sapiens_hsa03060 | 1.83609490 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82468347 |
14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81884905 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81609673 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80919240 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80311419 |
18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75238490 |
19 | DNA replication_Homo sapiens_hsa03030 | 1.75148412 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75087122 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74039200 |
22 | Ribosome_Homo sapiens_hsa03010 | 1.73535603 |
23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72908256 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70936920 |
25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69281666 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69033630 |
27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65907898 |
28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58428766 |
29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.58291379 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54889048 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49647811 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48602063 |
33 | Proteasome_Homo sapiens_hsa03050 | 1.46827746 |
34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43924010 |
35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42048948 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38736843 |
37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37600481 |
38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37333238 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33079983 |
40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30008405 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28045949 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26474100 |
43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.25585047 |
44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22579453 |
45 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22060151 |
46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21724805 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20725330 |
48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17874909 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16621530 |
50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12472653 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10869109 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10628853 |
53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10486682 |
54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10399762 |
55 | Homologous recombination_Homo sapiens_hsa03440 | 1.09734972 |
56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09266372 |
57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08634927 |
58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07656034 |
59 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04719528 |
60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04664694 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04128720 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03605617 |
63 | Asthma_Homo sapiens_hsa05310 | 1.02777467 |
64 | ABC transporters_Homo sapiens_hsa02010 | 1.01648037 |
65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00130855 |
66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99531244 |
67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99123980 |
68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99104694 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98437332 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.98204745 |
71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97252955 |
72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96741524 |
73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96150139 |
74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95859238 |
75 | Mismatch repair_Homo sapiens_hsa03430 | 0.95005241 |
76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92583132 |
77 | Base excision repair_Homo sapiens_hsa03410 | 0.92324796 |
78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91002102 |
79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90926807 |
80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90784295 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83077239 |
82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82346090 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80337856 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79635649 |
85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77971435 |
86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75825420 |
87 | Salmonella infection_Homo sapiens_hsa05132 | 0.74504092 |
88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72667588 |
89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71571481 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71341476 |
91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69400526 |
92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69171544 |
93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69097994 |
94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69090232 |
95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68580731 |
96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68333584 |
97 | Legionellosis_Homo sapiens_hsa05134 | 0.67767333 |
98 | Tuberculosis_Homo sapiens_hsa05152 | 0.66628040 |
99 | Malaria_Homo sapiens_hsa05144 | 0.66030019 |
100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65969020 |
101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65124285 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64488595 |
103 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.62865635 |
104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62619272 |
105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61669887 |
106 | Influenza A_Homo sapiens_hsa05164 | 0.59353475 |
107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59233605 |
108 | Bile secretion_Homo sapiens_hsa04976 | 0.58652687 |
109 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57895311 |
110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56423519 |
111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54461004 |
112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54236982 |
113 | Measles_Homo sapiens_hsa05162 | 0.52964381 |
114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52813159 |
115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52424885 |
116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51573740 |
117 | Pertussis_Homo sapiens_hsa05133 | 0.50530442 |
118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49314252 |
119 | RNA polymerase_Homo sapiens_hsa03020 | 0.47637953 |
120 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46662285 |
121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46455660 |
122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46125369 |
123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45610206 |
124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45148571 |
125 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44318046 |
126 | Allograft rejection_Homo sapiens_hsa05330 | 0.42509948 |
127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41644607 |
128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38570789 |
129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35382104 |
130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.35237785 |
131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35153188 |
132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35080922 |
133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34732196 |
134 | Lysosome_Homo sapiens_hsa04142 | 0.34349624 |